The Government of Pakistan has released announced the allocation of $150 million dollars for the coronavirus vaccine.
Pfizer and BioNTech that their COVID-19 vaccine candidate had 90% efficacy in clinical trials. Similar announcements about the Russian Sputnik V and Moderna vaccines followed soon after.
The $150 million had been booked for 10 million people in advance with at least two or three leading manufacturers who have entered into phase three trials and showing positive results.
The federal government of Pakistan has conditionally approved $150 million funds to procure the coronavirus vaccine for 5% of the country’s population.